Singulair Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Bioequivalence Study of Montelukast, 5 mg Chewable Tablets (Pharmtechnology LLC, Belarus), and Singulair ®, 5 mg Chewable Tablets (Merck Sharp & Dohme B.V., the Netherlands), in Healthy Volunteers Under Fasting Conditions
Condition:   Healthy Adults Interventions:   Drug: Montelukast;   Drug: Singulair Sponsors:   Pharmtechnology LLC;   ClinPharmInvest, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2019 Category: Research Source Type: clinical trials

Bioequivalence Study of Montelukast From Asmakast 5mg Chewable Tab.(Sandoz, Egypt) & Singulair 5mg Chewable Tab.(Merck)
Condition:   HealthyInterventions:   Drug: Asmakast;   Drug: SingulairSponsors:   Genuine Research Center, Egypt;   SandozCompleted - verified June 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2015 Category: Research Source Type: clinical trials